Consensus Enhabit, Inc.

Equities

EHAB

US29332G1022

Market Closed - Nyse Other stock markets 04:00:02 2024-05-15 pm EDT			5-day change	1st Jan Change
8.66 ^USD	-4.20%		-10.72%	-16.33%

May. 14	Leerink Partners Upgrades Enhabit to Market Perform From Underperform, Price Target is $8.50	MT
May. 10	UBS Trims Price Target on Enhabit to $9 From $10, Keeps Neutral Rating	MT

Evolution of the average Target Price on Enhabit, Inc.

Price target over the last 5 years

History of analyst recommendation changes

ee19bd.ZfaD4daaH7cCjllRhEkZvqaf2H3odlvrKIHhGL5m3d8.KsfgkO7DecBO5h0rtgh0yc7ligffGSKCTNKOe_oDh5girOGAtfJy9kPUDA~e3602acc657d76c097eac7d388c1d61d

Analyst Recommendations on Enhabit, Inc.

Leerink Partners Upgrades Enhabit to Market Perform From Underperform, Price Target is $8.50	May. 14	MT
UBS Trims Price Target on Enhabit to $9 From $10, Keeps Neutral Rating	May. 10	MT
Jefferies Downgrades Enhabit to Hold From Buy, Price Target at $8.75	May. 09	MT
UBS Adjusts Enhabit Price Target to $10 From $9.50, Maintains Neutral Rating	Mar. 08	MT
UBS Upgrades Enhabit to Neutral From Sell, $9.50 Price Target	Mar. 07	MT
Jefferies Adjusts Price Target on Enhabit to $14 From $15, Maintains Buy Rating	Mar. 06	MT
TD Cowen Starts Enhabit With Market Perform Rating	Dec. 12	MT
Credit Suisse Adjusts Enhabit's Price Target to $12 From $15, Keeps Neutral Rating	23-08-11	MT
Goldman Sachs Adjusts Price Target on Enhabit to $13 From $15, Maintains Neutral Rating	23-07-17	MT
UBS Adjusts Enhabit Price Target to $9.50 From $11, Maintains Sell Rating	23-05-12	MT
Goldman Sachs Starts Enhabit at Neutral With $15 Price Target	23-03-16	MT
CJS Securities Initiates Coverage on Enhabit With Market Perform Rating, $18 Price Target	22-12-13	MT
UBS Initiates Coverage on Enhabit With Sell Rating, $12 Price Target	22-12-08	MT
Stifel Starts Enhabit at Buy With $17 Price Target	22-12-06	MT
Credit Suisse Lowers Enhabit's Price Target to $15 From $19 on Further Mix Shift, Labor Cost Pressures; Keeps Neutral Rating	22-11-04	MT
Oppenheimer Initiates Coverage on Enhabit With Perform Rating	22-10-14	MT
Jefferies Initiates Enhabit at Buy with $20 Price Target	22-08-30	MT
Credit Suisse Initiates Enhabit at Neutral with $19 Price Target, Says Mid-to-High Single-Digit Annual Organic Growth Possible Long-Term	22-08-25	MT
RBC Cuts Price Target on Encompass Health to $66 From $82, Citing Enhabit Home Health & Hospice Spinoff, Maintains Outperform Rating	22-08-24	MT
Citigroup Initiates Enhabit at Neutral With $17 Price Target	22-08-18	MT
BofA Securities Initiates Enhabit at Underperform With $16 Price Target	22-07-13	MT